Hikma Pharmaceuticals (LON:HIK) Reaches New 52-Week Low - Time to Sell?

Key Points

• Hikma Pharmaceuticals' shares reached a new 52-week low of GBX 1,690 ($22.58), closing at GBX 1,747 ($23.34) with significant trading volume of 3,202,372 shares.
• Jefferies Financial Group reaffirmed a “buy” rating for Hikma Pharmaceuticals, setting a price target of GBX 2,600 ($34.73) per share.
• Insider Said Darwazah sold 13,863 shares for £296,390.94 ($395,926.98), indicating a significant level of insider investment in the company.

Shares of Hikma Pharmaceuticals PLC (LON:HIK - Get Free Report) hit a new 52-week low on Thursday . The stock traded as low as GBX 1,690 ($22.58) and last traded at GBX 1,747 ($23.34), with a volume of 3202372 shares traded. The stock had previously closed at GBX 1,884 ($25.17).

Analyst Ratings Changes

Separately, Jefferies Financial Group reissued a "buy" rating and set a GBX 2,600 ($34.73) price target on shares of Hikma Pharmaceuticals in a research report on Thursday.

Hikma Pharmaceuticals Price Performance

The company has a current ratio of 1.66, a quick ratio of 1.27 and a debt-to-equity ratio of 55.82. The firm's 50-day moving average price is GBX 2,031.24 and its two-hundred day moving average price is GBX 2,056.16. The stock has a market cap of £4.90 billion, a PE ratio of 17.33, a PEG ratio of 2.38 and a beta of 0.41.

Insider Transactions at Hikma Pharmaceuticals

In other Hikma Pharmaceuticals news, insider Said Darwazah sold 13,863 shares of the stock in a transaction dated Friday, May 30th. The shares were sold at an average price of GBX 2,138 ($28.56), for a total transaction of £296,390.94 ($395,926.98). 30.54% of the stock is owned by company insiders.

About Hikma Pharmaceuticals

At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.